Clinical Trials · NCT03007979
Alternative Dosing Schedule of Palbociclib in Metastatic Hormone Receptor Positive Breast Cancer
- Phase
- Phase 2
- Recruitment status
- Completed
- Sponsor
- Washington University School of Medicine
- Enrollment
- 55
- Start date
- Jun 2017
- Locations
- 2 sites, United States
- Primary endpoint
- Rate of Grade 3 or Higher Neutropenia